These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 3277664

  • 1. A double-crossover trial comparing the effects of topical carteolol and placebo on intraocular pressure.
    Duff GR, Graham PA.
    Br J Ophthalmol; 1988 Jan; 72(1):27-8. PubMed ID: 3277664
    [Abstract] [Full Text] [Related]

  • 2. The 12-hour control of intraocular pressure on carteolol 2% twice daily.
    Duff GR, Newcombe RG.
    Br J Ophthalmol; 1988 Dec; 72(12):890-1. PubMed ID: 3067744
    [Abstract] [Full Text] [Related]

  • 3. A double-masked comparison of carteolol and timolol in ocular hypertension.
    Scoville B, Mueller B, White BG, Krieglstein GK.
    Am J Ophthalmol; 1988 Feb 15; 105(2):150-4. PubMed ID: 3277436
    [Abstract] [Full Text] [Related]

  • 4. A double-masked crossover study comparing the effects of carteolol 1% and 2% on intra-ocular pressure.
    Duff GR.
    Acta Ophthalmol (Copenh); 1987 Oct 15; 65(5):618-21. PubMed ID: 3321878
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the ocular hypotensive efficacy and systemic safety of 0.5% levobunolol and 2% carteolol.
    Behrens-Baumann W, Kimmich F, Walt JG, Lue J.
    Ophthalmologica; 1994 Oct 15; 208(1):32-6. PubMed ID: 8145982
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Carteolol: general practice-oriented assessment of the effectiveness and tolerance of a new beta-blocker in the treatment of glaucoma].
    Schnaudigel OE, Becker H, Fuchs HB.
    Klin Monbl Augenheilkd; 1988 Mar 15; 192(3):248-51. PubMed ID: 3374015
    [Abstract] [Full Text] [Related]

  • 9. Carteolol: preliminary study on ocular pressure-reducing action.
    Gorgone G, Spina F, Amantia L.
    Ophthalmologica; 1983 Mar 15; 187(3):171-3. PubMed ID: 6355953
    [Abstract] [Full Text] [Related]

  • 10. [Aqueous humor flow measured by fluorophotometry. A comparative study of the effect of various beta-blocker eyedrops in patients with ocular hypertension].
    Coulangeon LM, Sole M, Menerath JM, Sole P.
    Ophtalmologie; 1990 Mar 15; 4(2):156-61. PubMed ID: 2235007
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of 0.004% travoprost and 2% carteolol on intraocular pressure in patients with ocular hypertension after laser peripheral iridotomy or trabeculectomy in primary angle-closure glaucoma].
    Yao BQ, Pang YY, Li YX.
    Zhonghua Yan Ke Za Zhi; 2013 Apr 15; 49(4):340-4. PubMed ID: 23900094
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antihypertensive effect of carteolol in thiazide-treated hypertensive subjects.
    Velasquez MT, Byrne D, Hoffmann RG.
    J Clin Pharmacol; 1985 Apr 15; 25(8):601-6. PubMed ID: 3908501
    [Abstract] [Full Text] [Related]

  • 16. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
    Sirbat D, Charlin JF, Cohn H, Dascotte JC, George JL, Lesure P, Massin M, Massin G, Maurin JF, Renard JP.
    J Fr Ophtalmol; 1995 Apr 15; 18(10):589-96. PubMed ID: 8568162
    [Abstract] [Full Text] [Related]

  • 17. [Clinical experiences with carteolol in patients with essential hypertension].
    Viehmann P.
    Arzneimittelforschung; 1983 Apr 15; 33(2a):322-5. PubMed ID: 6340701
    [Abstract] [Full Text] [Related]

  • 18. Hypotensive effect of carteolol on intraocular pressure elevation and secondary glaucoma associated with endogenous uveitis.
    Ohno S, Ichiishi A, Matsuda H.
    Ophthalmologica; 1989 Apr 15; 199(1):41-5. PubMed ID: 2761985
    [Abstract] [Full Text] [Related]

  • 19. [Hypotensive action of 0.5% carteolol versus 0.1% timolol in patients with intraocular hypertension].
    Allaire C, Trinquand C, Nordmann JP, Dascotte JC, George JL, Lesure P, Rouland JF, Khaitrine L, Sirbat D.
    J Fr Ophtalmol; 1995 Apr 15; 18(1):22-6. PubMed ID: 7738291
    [Abstract] [Full Text] [Related]

  • 20. Remission of mild to moderate hypertension after treatment with carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity.
    Giles TD, Sander GE, Roffidal L, Thomas MG, Mersch DP, Moyer RR, Burris JF, Mroczek WJ, Brachfeld J.
    Arch Intern Med; 1988 Aug 15; 148(8):1725-8. PubMed ID: 3041936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.